» Articles » PMID: 29893868

Microtubule Cytoskeleton Regulates Connexin 43 Localization and Cardiac Conduction in Cardiomyopathy Caused by Mutation in A-type Lamins Gene

Overview
Journal Hum Mol Genet
Date 2018 Jun 13
PMID 29893868
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in the lamin A/C gene (LMNA) cause an autosomal dominant inherited form of dilated cardiomyopathy associated with cardiac conduction disease (hereafter referred to as LMNA cardiomyopathy). Compared with other forms of dilated cardiomyopathy, mutations in LMNA are responsible for a more aggressive clinical course owing to a high rate of malignant ventricular arrhythmias. Gap junctions are intercellular channels that allow direct communication between neighboring cells, which are involved in electrical impulse propagation and coordinated contraction of the heart. For gap junctions to properly control electrical synchronization in the heart, connexin-based hemichannels must be correctly targeted to intercalated discs, Cx43 being the major connexin in the working myocytes. We here showed an altered distribution of Cx43 in a mouse model of LMNA cardiomyopathy. However, little is known on the molecular mechanisms of Cx43 remodeling in pathological context. We now show that microtubule cytoskeleton alteration and decreased acetylation of α-tubulin lead to remodeling of Cx43 in LMNA cardiomyopathy, which alters the correct communication between cardiomyocytes, ultimately leading to electrical conduction disturbances. Preventing or reversing this process could offer a strategy to repair damaged heart. Stabilization of microtubule cytoskeleton using Paclitaxel improved intraventricular conduction defects. These results indicate that microtubule cytoskeleton contributes to the pathogenesis of LMNA cardiomyopathy and that drugs stabilizing the microtubule may be beneficial for patients.

Citing Articles

Understanding the Role of Connexins in Hepatocellular Carcinoma: Molecular and Prognostic Implications.

Papadakos S, Chatzikalil E, Arvanitakis K, Vakadaris G, Stergiou I, Koutsompina M Cancers (Basel). 2024; 16(8).

PMID: 38672615 PMC: 11048329. DOI: 10.3390/cancers16081533.


Characterization of cardiac involvement in patients with splice-site mutation-related dilated cardiomyopathy and sudden cardiac death.

Ling X, Hou Y, Jia X, Lan Y, Wu X, Wu J Front Genet. 2024; 14:1291411.

PMID: 38259623 PMC: 10800368. DOI: 10.3389/fgene.2023.1291411.


Pharmacotherapeutic Approaches to Treatment of Muscular Dystrophies.

Rawls A, Diviak B, Smith C, Severson G, Acosta S, Wilson-Rawls J Biomolecules. 2023; 13(10).

PMID: 37892218 PMC: 10605463. DOI: 10.3390/biom13101536.


Targeting unfolded protein response reverts ER stress and ER Ca homeostasis in cardiomyocytes expressing the pathogenic variant of Lamin A/C R321X.

Pietrafesa G, De Zio R, Scorza S, Armentano M, Pepe M, Forleo C J Transl Med. 2023; 21(1):340.

PMID: 37217929 PMC: 10204200. DOI: 10.1186/s12967-023-04170-y.


Nesprin-1: novel regulator of striated muscle nuclear positioning and mechanotransduction.

De Silva S, Fan Z, Kang B, Shanahan C, Zhang Q Biochem Soc Trans. 2023; 51(3):1331-1345.

PMID: 37171063 PMC: 10317153. DOI: 10.1042/BST20221541.